StonvexLoading…
StonvexStonvexStonvexCore line items from CSX's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $14.09B | $14.54B | $14.66B | $14.85B |
Operating Income | $4.52B | $5.25B | $5.50B | $5.95B |
Net Income | $2.89B | $3.47B | $3.67B | $4.11B |
EPS (Diluted) | $1.54 | $1.79 | $1.82 | $1.92 |
Total Assets | $43.68B | $42.76B | $42.20B | $41.68B |
Total Liabilities | $30.52B | $30.26B | $30.23B | $29.21B |
Cash & Equivalents | $670.00M | $933.00M | $1.35B | $1.96B |
Free Cash Flow OCF − CapEx | $1.71B | $2.72B | $3.26B | $3.41B |
Shares Outstanding | 1.86B | 1.90B | 1.96B | 2.07B |